$176 Million Grant Boosts Pandemic Flu Vaccine Development
US Government Invests in Public Health Preparedness
Targeting H5 Avian Influenza for Pandemic Prevention
Project Aims to Enhance Pandemic Response Capabilities
Moderna's Phase I/II Trial Tests mRNA-1018 Vaccine
Trial Results Expected in 2024 to Guide Further Development
mRNA Technology Offers Advantages in Vaccine Development
Moderna Committed to Collaboration for Global Health
US Government Funds This Important Initiative
Moderna Receives FDA Approval for Another mRNA Vaccine